Effect of Ticagrelor on Endothelial Function
NCT01805596 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2016-10-05
Summary
This study is to assess the function of blood vessels while being treated with different types of blood thinners to determine the effect of these medications on blood vessels.
Conditions
- Coronary Artery Disease
- Endothelial Function
Interventions
- DRUG
-
clopidogrel
- DRUG
-
Ticagrelor
Sponsors & Collaborators
-
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
lead OTHER
Principal Investigators
-
Shahar Lavi, MD · London Health Sciences Centre
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-04-30
- Primary Completion
- 2016-02-29
- Completion
- 2016-07-31
Countries
- Canada
Study Locations
More Related Trials
-
Ticagrelor vs. Clopidogrel in Post PCI Patients
NCT05858918 ·Status: COMPLETED ·Phase: NA
-
Ticagrelor And PrEconditioning in Patients With coronaRy Artery diSease
NCT02701140 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Optimal Strategy of Switching From Clopidogrel to Ticagrelor in Patients With Complexity of Coronary Artery Disease
NCT03577652 ·Status: COMPLETED ·Phase: NA
-
Clopidogrel And Ticagrelor in Healthy Subjects
NCT02086903 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Ticagrelor And Clopidogrel on Inflammatory Biomarkers And Vascular Endothelial Function
NCT02123004 ·Status: UNKNOWN ·Phase: PHASE4
-
Ticagrelor Versus Clopidogrel in Type 2 Diabetic Patients
NCT01823510 ·Status: COMPLETED ·Phase: PHASE4
-
Compare Ticagrelor vs Clopidogrel on the Reduction of Arterial Stiffness and Wave Reflectionsin Patients With CAD.
NCT02071212 ·Status: COMPLETED ·Phase: PHASE2
-
A Pharmacodynamic Study With Ticagrelor in Hispanic Patients
NCT01523366 ·Status: COMPLETED ·Phase: PHASE4
-
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
NCT01732822 ·Status: COMPLETED ·Phase: PHASE3
-
Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.
NCT02052635 ·Status: TERMINATED ·Phase: PHASE4
-
A Randomized, Pharmacodynamic Comparison of Low Dose Ticagrelor to Clopidogrel in Patients With Prior Myocardial Infarction
NCT02663713 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention
NCT06228456 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-responders
NCT00642811 ·Status: COMPLETED ·Phase: PHASE2
-
Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease
NCT02287909 ·Status: COMPLETED ·Phase: PHASE4
-
Low-dose of Ticagrelor and Standard-dose Clopidogrel on Platelet Effects in Chinese Patients With Stable CAD.
NCT03679091 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation
NCT01905566 ·Status: COMPLETED ·Phase: PHASE4
-
Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
NCT02233790 ·Status: UNKNOWN ·Phase: PHASE4
-
Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
NCT02169596 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of Ticagrelor
NCT01812330 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of Effects of Ticagrelor on Microparticles and Micro-RNA in NSTE-ACS
NCT02071966 ·Status: TERMINATED ·Phase: PHASE4
-
Effect of Modifying Anti-platelet Treatment to Ticagrelor in Patients With Diabetes and Low Response to Clopidogrel
NCT01643031 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Ticagrelor and Clopidogrel on Coronary Microcirculation in Patients With Acute Myocardial Infarction
NCT03104062 ·Status: COMPLETED ·Phase: NA
-
Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy
NCT01823185 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Assess Pharmacokinetics, Pharmacodynamics and Safety of Tiprogrel in Healthy Subjects
NCT06584812 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
NCT02319941 ·Status: COMPLETED ·Phase: PHASE2